BIO Digital 2021
Novartis, Molecular Partners launch trial to test ensovibep as COVID treatment
The EMPHATHY clinical trial will enroll patients with COVID-19 to test the drug’s effectiveness in preventing worsening of symptoms and hospitalization.
BIO Digital 2021
The EMPHATHY clinical trial will enroll patients with COVID-19 to test the drug’s effectiveness in preventing worsening of symptoms and hospitalization.
The trial services firm has entered an acquisition agreement with Thoma Bravo, a private equity company centered on software and technology services.
According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.